The roadblocks to personalised treatment
Molecular Profiling is rapidly emerging as the most effective way for women to receive personalised treatment options. However, several barriers are still preventing many women from accessing this crucial advancement.
Current tests are costly.
Without more funding, molecular profiling is limited to patients who can afford it or are enrolled in research programs that include this testing.
Research is limited
Even with molecular profiling available, there is still limited research into the safest and most accessible treatment options because of the volume of sub-types of gynaecological cancers.
Access is difficult
Australia’s vast geography makes access to personalised treatments challenging outside major cities. Socioeconomic factors further complicate this, leaving many without the care they need.
The pathway to transformation
All of these challenges can be met with the right resources and ANZGOG’s members are leading oncologists that are tackling these challenges directly with your support.
Work together efficiently
By securing more resources, ANZGOG aims to build a collaborative solution that gives doctors faster, more affordable access to molecular profiling, comprehensive treatment information, and guidance on personalising care for each patient.
Advance more research
More funding will drive innovation in data and research to improve early diagnosis and prevention, especially for cancers where tests are not yet available as well as support flexible clinical trials–both academic and industry developed with faster outcomes.
Easier access to research
We are working in partnership to bring more research trials to Australian patients, providing doctors and patients with quicker, easier access to life-saving treatments and research innovations.
"With increased awareness and access to molecular profile testing, it will transform the treatment pathway. It would be no different from doing a blood type or a chest X ray and should become standard practice."
Dr. George Au-Yeung
